liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Principles of Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children with Idiopathic Short Stature
Karolinska Institute and University Hospital.
2011 (English)In: HORMONE RESEARCH IN PAEDIATRICS, ISSN 1663-2818, Vol. 76, no s3, 24-26 p.Article in journal (Refereed) Published
Abstract [en]

Until recently, growth hormone (GH) was the only treatment available to improve growth rate in short, prepubertal children. Insulinlike growth factor I (IGF-I) is now approved in the United States and the European Union for treatment of short stature in children with severe primary IGF-I deficiency, a condition characterized by unresponsiveness to GH in IGF-I-producing tissues. This has increased the focus on the growth response to GH therapy in short children treated according to current recommendations. In particular, children with idiopathic short stature (ISS) may have some degree of GH insensitivity that decreases their response to GH treatment. This minireview discusses data on the response to GH treatment in patients with ISS and recent studies on the use of IGF-I in subgroups of patients with ISS. The rationale for future combination treatment with GH plus IGF-I is also discussed.

Place, publisher, year, edition, pages
2011. Vol. 76, no s3, 24-26 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-73942DOI: 10.1159/000330148OAI: diva2:478974
Available from: 2012-01-17 Created: 2012-01-17 Last updated: 2012-02-21

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Bang, Peter
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 31 hits
ReferencesLink to record
Permanent link

Direct link